Variant report
Variant | esv2422034 |
---|---|
Chromosome Location | chr6:31219803-31229678 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:31209841..31212396-chr6:31219604..31221505,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs199503244 | chr6:31220200-31220201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs370063127 | chr6:31220202-31220203 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs9264191 | chr6:31220232-31220233 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
4 | rs7449932 | chr6:31220244-31220245 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
5 | rs7452529 | chr6:31220253-31220254 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
6 | rs2394941 | chr6:31220273-31220274 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
7 | rs537114823 | chr6:31220275-31220276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs73728467 | chr6:31220309-31220310 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs137958971 | chr6:31220315-31220316 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs3095257 | chr6:31220318-31220319 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
11 | rs386698915 | chr6:31220364-31220365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs4473905 | chr6:31220369-31220370 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
13 | rs2394943 | chr6:31220388-31220389 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
14 | rs542543750 | chr6:31220389-31220390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs386698916 | chr6:31220421-31220422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs73728468 | chr6:31220425-31220426 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs114506115 | chr6:31220426-31220427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs117378644 | chr6:31220428-31220429 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs116506047 | chr6:31220440-31220441 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs2394944 | chr6:31220450-31220451 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
21 | rs559381810 | chr6:31220470-31220471 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs186128418 | chr6:31220473-31220474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs112445290 | chr6:31220483-31220484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs111470335 | chr6:31220490-31220491 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs112431221 | chr6:31220506-31220507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs117836273 | chr6:31220534-31220535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs9279056 | chr6:31220549-31220550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs386698917 | chr6:31220552-31220553 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs530843226 | chr6:31220557-31220558 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs190527790 | chr6:31220562-31220563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs3134747 | chr6:31220567-31220568 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
32 | rs374652752 | chr6:31220647-31220648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs114418536 | chr6:31220648-31220649 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs182732680 | chr6:31220656-31220657 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs140423547 | chr6:31220725-31220726 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs371490180 | chr6:31220726-31220727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs201246838 | chr6:31220729-31220730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs199860764 | chr6:31220730-31220731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs3134746 | chr6:31220752-31220753 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
40 | rs187799612 | chr6:31220754-31220755 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs3130436 | chr6:31220783-31220784 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
42 | rs186297002 | chr6:31220785-31220786 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs550069316 | chr6:31220787-31220788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs574773987 | chr6:31227206-31227207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs189195118 | chr6:31227218-31227219 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs9264327 | chr6:31227219-31227220 | Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
47 | rs150543164 | chr6:31227236-31227237 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs9264328 | chr6:31227250-31227251 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
49 | rs9264329 | chr6:31227254-31227255 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
50 | rs9264330 | chr6:31227263-31227264 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
abnormal development | 18461090 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Systemic lupus erythematosus | 20877625 | CNVD |
Cleidocranial dysplasia | 18696259 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Liposarcoma | 21253554 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Fibroblasts | 20926602 | CNVD |
Breast cancer | 21364760 | CNVD |
Systemic lupus erythematosus | 19279649 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Acute myocardial infarction | 18032375 | CNVD |
Renal cell carcinoma | 19150565 | CNVD |
Systemic lupus erythematosus | 19591781 | CNVD |
Attention deficit hyperactivity disorder | 19287146 | CNVD |
Autism | 19287146 | CNVD |
Erythema nodosum in leprosy | 19287146 | CNVD |
Henoch-schoenlein purpura | 19287146 | CNVD |
Liver cirrhosis | 19287146 | CNVD |
Systemic lupus erythematosus | 19287146 | CNVD |
Congenital adrenal hyperplasia | 18478071 | CNVD |
Systemic lupus erythematosus | 19287147 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Melanoma | 20877625 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:31220200-31220600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
2 | chr6:31220200-31220600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr6:31220200-31220800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr6:31220400-31220800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr6:31227200-31228400 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
6 | chr6:31227200-31228800 | Enhancers | Primary T helper naive cells fromperipheralblood | blood |
7 | chr6:31227200-31228800 | Enhancers | Primary T regulatory cells fromperipheralblood | blood |
8 | chr6:31227400-31228400 | Enhancers | Primary T cells fromperipheralblood | blood |
9 | chr6:31227600-31228200 | Enhancers | Primary B cells from peripheral blood | blood |
10 | chr6:31227600-31229200 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
11 | chr6:31227800-31228400 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
12 | chr6:31227800-31228400 | Enhancers | Primary T killer naive cells fromperipheralblood | blood |
13 | chr6:31227800-31228600 | Enhancers | Primary T helper cells fromperipheralblood | blood |
14 | chr6:31228000-31228200 | Enhancers | Fetal Thymus | thymus |
15 | chr6:31228000-31228400 | Enhancers | Primary T cells effector/memory enriched fromperipheralblood | blood |
16 | chr6:31228000-31228400 | Enhancers | Primary T killer memory cells from peripheral blood | blood |
17 | chr6:31228000-31228600 | Enhancers | Primary T helper naive cells from peripheral blood | blood |
18 | chr6:31228000-31228800 | Enhancers | Primary T helper memory cells from peripheral blood 1 | blood |
19 | chr6:31228200-31235800 | Weak transcription | Fetal Thymus | thymus |
20 | chr6:31228400-31233800 | Weak transcription | Primary T cells fromperipheralblood | blood |
21 | chr6:31228400-31235400 | Weak transcription | Primary T helper memory cells from peripheral blood 2 | blood |
22 | chr6:31228600-31234800 | Weak transcription | Primary T helper naive cells from peripheral blood | blood |